Physician profile
Jonathan T Carter
NPI 1194854067
$9,277.49
in general payments reported to CMS, 2019-2025
7 companies · $1,716 in 2025
The $1,716 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $204 · 2021: $401 · 2022: $1,487 · 2023: $2,356 · 2024: $2,647 · 2025: $1,716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,819 · Education: $1,500 · Honoraria: $900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,818.98 |
| Education | $1,500.00 |
| Honoraria | $900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,147.62 | 2020-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $2,700.74 | 2021-2025 | Signia, Ligasure, Progrip |
| Davol INC. | $2,291.16 | 2021-2025 | Phasix Mesh |
| Asensus Surgical, INC. | $600.00 | 2022 | |
| Covidien LP | $416.83 | 2019 | |
| Ethicon US, LLC | $91.60 | 2019-2025 | Stratafix |
| Becton, Dickinson and Company | $29.54 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.